Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Choosing between two healthcare giants comes down to balance: steady income or longer-term growth. This guide dives i...
CoreWeave delivers a record bookings quarter but sinks on concentration fears, while QQQ holds steady amid AI volatil...
In the first half of 2026, american superconductor corporation rallied as grid modernization and superconducting tech...
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
Duolingo stock fell February as investors reeled from a shaky user metric and rising AI disruption concerns. This art...
When dollar general stock dips, investors often worry about consumer weakness or policy shifts. This guide breaks dow...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...
A 70,000-seat return in a government-backed venue stirs more than cheers. This article breaks down the money side of ...